These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8855146)

  • 1. Analytical performance and clinical usefulness of a commercially available IRMA kit for measuring atrial natriuretic peptide in patients with heart failure.
    Clerico A; Iervasi G; Del Chicca MG; Maffei S; Berti S; Sabatino L; Turchi S; Cazzuola F; Manfredi C; Biagini A
    Clin Chem; 1996 Oct; 42(10):1627-33. PubMed ID: 8855146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.
    Clerico A; Iervasi G; Del Chicca MG; Emdin M; Maffei S; Nannipieri M; Sabatino L; Forini F; Manfredi C; Donato L
    J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method.
    Del Ry S; Clerico A; Giannessi D; Andreassi MG; Caprioli R; Iascone MR; Ferrazzi P; Biagini A
    Scand J Clin Lab Invest; 2000 Apr; 60(2):81-90. PubMed ID: 10817394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
    Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
    Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoradiometric assay of atrial natriuretic peptide in unextracted plasma.
    Tattersall JE; Dawnay A; McLean C; Cattell WR
    Clin Chem; 1990 Jun; 36(6):855-9. PubMed ID: 2141557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide is not degraded by the lungs in humans.
    Iervasi G; Clerico A; Pilo A; Sabatino L; Manfredi ; Forini F; Del Chicca MG; Palmieri C; Ravani M; Donato L
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2898-906. PubMed ID: 9709966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of N-terminal pro-atrial natriuretic peptide and atrial natriuretic peptide in human plasma as measured with commercially available radioimmunoassay kits.
    Boomsma F; Bhaggoe UM; Man in 't Veld AJ; Schalekamp MA
    Clin Chim Acta; 1996 Aug; 252(1):41-9. PubMed ID: 8814360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation.
    Shimamoto K; Kusumoto M; Sakai R; Watanabe H; Ihara S; Koike N; Kawana M
    Can J Cardiol; 2007 Mar; 23(4):295-300. PubMed ID: 17380223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial pressure and secretion of atrial natriuretic factor into the human central circulation.
    Rodeheffer RJ; Tanaka I; Imada T; Hollister AS; Robertson D; Inagami T
    J Am Coll Cardiol; 1986 Jul; 8(1):18-26. PubMed ID: 2940286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma atrial natriuretic peptide values in cardiac disease.
    Lang RE; Dietz R; Merkel A; Unger T; Ruskoaho H; Ganten D
    J Hypertens Suppl; 1986 Jun; 4(2):S119-23. PubMed ID: 2941533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered tissue degradation and distribution of atrial natriuretic peptide in patients with idiopathic dilated cardiomyopathy and its relationship with clinical severity of the disease and sodium handling.
    Iervasi G; Clerico A; Berti S; Pilo A; Biagini A; Bianchi R; Donato L
    Circulation; 1995 Apr; 91(7):2018-27. PubMed ID: 7895361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoradiometric assay for the N-terminal fragment of proatrial natriuretic peptide in human plasma.
    Numata Y; Dohi K; Furukawa A; Kikuoka S; Asada H; Fukunaga T; Taniguchi Y; Sasakura K; Tsuji T; Inouye K; Yoshimura M; Itoh H; Mukoyama M; Yasue H; Nakao K
    Clin Chem; 1998 May; 44(5):1008-13. PubMed ID: 9590374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure.
    Haug C; Metzele A; Kochs M; Hombach V; Grünert A
    Clin Cardiol; 1993 Jul; 16(7):553-7. PubMed ID: 8348764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between heart disorders and concentrations of directly measured atrial natriuretic peptide in plasma.
    Fridrich L; Szekeres T; Hartter E; Schweighofer F; Gassner A; Laczkovic A
    Clin Chem; 1989 Mar; 35(3):435-9. PubMed ID: 2522027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma brain natriuretic peptide measured by fully-automated immunoassay and by immunoradiometric assay compared.
    Del Ry S; Giannessi D; Clerico A
    Clin Chem Lab Med; 2001 May; 39(5):446-50. PubMed ID: 11434395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma atrial natriuretic polypeptide as an index of left ventricular end-diastolic pressure in patients with chronic left-sided heart failure.
    Tsutamoto T; Bito K; Kinoshita M
    Am Heart J; 1989 Mar; 117(3):599-606. PubMed ID: 2521973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and analytical evaluation of an immunoradiometric assay for corticotropin.
    Rosano TG; Demers LM; Hillam R; Dybas MT; Leinung M
    Clin Chem; 1995 Jul; 41(7):1022-7. PubMed ID: 7600682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction.
    Lerman A; Gibbons RJ; Rodeheffer RJ; Bailey KR; McKinley LJ; Heublein DM; Burnett JC
    Lancet; 1993 May; 341(8853):1105-9. PubMed ID: 8097801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.